Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Project cooperationUpdated on 16 April 2026

Dual control colonic delivery system

Sonia Thomson

Communication specialist at Biotechnet Switzerland

Muttenz, Switzerland

About

The FHNW School of Life Sciences (a member of Biotechnet) is seeking to out-licence or further develop a dual control colonic delivery system. It is a pharmaceutical dosage form for (per)oral administration that allows targeted release of an active pharmaceutical ingredient (API), or a live biotherapeutic agent in the colonaiming at antiinflammation, immunomodulation, immunosuppression, establishing, re-establishing, and/or modifying the balance of the microbiome in the colon or the physiology of the lower gastrointestinal tract.

See patents and publications:

IP rights: WO2020048979A1

Key publications:

https://doi.org/10.1016/j.ijpharm.2022.122499
https://doi.org/10.1016/j.jconrel.2023.04.047
https://doi.org/10.1016/j.xphs.2024.05.020

Topic

  • Biotech, Pharma and Cosmetics

Type

  • Research
  • Other

Organisation

Biotechnet Switzerland

Association/Agency

Muttenz, Switzerland

Similar opportunities